pyrrolopyrrolyl isoquinoline derivative (National Institutes of Pharmaceutical Research and Development)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namepyrrolopyrrolyl isoquinoline derivative (National Institutes of Pharmaceutical Research and Development)
Drug Alias Name4-fluoro-5-((6-methylhexahydropyrrolo[3,4-b] pyrrol-5(1H)-yl) sulfonyl) (isoquinoline)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNational Institutes Of Pharmaceutical Research And Development Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNational Institutes Of Pharmaceutical Research And Development Co Ltd
Inactive CompaniesN/A
Active IndicationsIdiopathic Pulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A